BusinessAXIM Biotech Enters Clinical Study Agreement with University of British Columbia to Begin Clinical Trial On CBD Chewing Gum For Treatment of Drug-Related PsychosisBy Nasdaq OMXAug 2, 2017, 1:01 PM UTC
BusinessAXIM Biotech Advisory Board Member Presented at CannMed 2017 Personalized Cannabinoid Medicine Conference at HarvardBy Nasdaq OMXApr 13, 2017, 1:01 PM UTC
BusinessAXIM Biotech Advisory Board Member Presented at CannMed 2017 Personalized Cannabinoid Medicine Conference at HarvardBy Nasdaq OMXApr 13, 2017, 1:01 PM UTC
